Global Spinal Devices and Biologics Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Spinal Devices and Biologics market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Spinal Devices and Biologics market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Spinal Devices and Biologics market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Spinal Devices and Biologics market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Spinal Devices and Biologics market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Spinal Devices and Biologics market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Spinal Devices and Biologics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Spinal Devices and Biologics market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Nuvasive, Orthofix International, Exactech, Wright Medical Group and Johnson & Johnson, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Spinal Devices and Biologics market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Spinal Devices and Biologics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Spinal Devices and Biologics, with price, sales, revenue and global market share of Spinal Devices and Biologics from 2018 to 2023.
Chapter 3, the Spinal Devices and Biologics competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Spinal Devices and Biologics breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Spinal Devices and Biologics market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Spinal Devices and Biologics.
Chapter 14 and 15, to describe Spinal Devices and Biologics sales channel, distributors, customers, research findings and conclusion.
This report is a detailed and comprehensive analysis for global Spinal Devices and Biologics market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Spinal Devices and Biologics market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Spinal Devices and Biologics market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Spinal Devices and Biologics market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Spinal Devices and Biologics market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Spinal Devices and Biologics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Spinal Devices and Biologics market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Nuvasive, Orthofix International, Exactech, Wright Medical Group and Johnson & Johnson, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Spinal Devices and Biologics market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Spinal Fusion & Fixation
- Motion Preservation
- Non-Fusion Technologies
- Fracture Treatment
- Others
- Hospitals
- Ambulatory Surgical Centers
- Clinics
- Others
- Nuvasive
- Orthofix International
- Exactech
- Wright Medical Group
- Johnson & Johnson
- Zimmer Biomet
- Globus Medical
- K2M
- Medtronic
- Alphatec Holdings
- RTI Surgical
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Spinal Devices and Biologics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Spinal Devices and Biologics, with price, sales, revenue and global market share of Spinal Devices and Biologics from 2018 to 2023.
Chapter 3, the Spinal Devices and Biologics competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Spinal Devices and Biologics breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Spinal Devices and Biologics market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Spinal Devices and Biologics.
Chapter 14 and 15, to describe Spinal Devices and Biologics sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Spinal Devices and Biologics
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Spinal Devices and Biologics Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Spinal Fusion & Fixation
1.3.3 Motion Preservation
1.3.4 Non-Fusion Technologies
1.3.5 Fracture Treatment
1.3.6 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Spinal Devices and Biologics Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospitals
1.4.3 Ambulatory Surgical Centers
1.4.4 Clinics
1.4.5 Others
1.5 Global Spinal Devices and Biologics Market Size & Forecast
1.5.1 Global Spinal Devices and Biologics Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Spinal Devices and Biologics Sales Quantity (2018-2029)
1.5.3 Global Spinal Devices and Biologics Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Nuvasive
2.1.1 Nuvasive Details
2.1.2 Nuvasive Major Business
2.1.3 Nuvasive Spinal Devices and Biologics Product and Services
2.1.4 Nuvasive Spinal Devices and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Nuvasive Recent Developments/Updates
2.2 Orthofix International
2.2.1 Orthofix International Details
2.2.2 Orthofix International Major Business
2.2.3 Orthofix International Spinal Devices and Biologics Product and Services
2.2.4 Orthofix International Spinal Devices and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Orthofix International Recent Developments/Updates
2.3 Exactech
2.3.1 Exactech Details
2.3.2 Exactech Major Business
2.3.3 Exactech Spinal Devices and Biologics Product and Services
2.3.4 Exactech Spinal Devices and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Exactech Recent Developments/Updates
2.4 Wright Medical Group
2.4.1 Wright Medical Group Details
2.4.2 Wright Medical Group Major Business
2.4.3 Wright Medical Group Spinal Devices and Biologics Product and Services
2.4.4 Wright Medical Group Spinal Devices and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Wright Medical Group Recent Developments/Updates
2.5 Johnson & Johnson
2.5.1 Johnson & Johnson Details
2.5.2 Johnson & Johnson Major Business
2.5.3 Johnson & Johnson Spinal Devices and Biologics Product and Services
2.5.4 Johnson & Johnson Spinal Devices and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Johnson & Johnson Recent Developments/Updates
2.6 Zimmer Biomet
2.6.1 Zimmer Biomet Details
2.6.2 Zimmer Biomet Major Business
2.6.3 Zimmer Biomet Spinal Devices and Biologics Product and Services
2.6.4 Zimmer Biomet Spinal Devices and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Zimmer Biomet Recent Developments/Updates
2.7 Globus Medical
2.7.1 Globus Medical Details
2.7.2 Globus Medical Major Business
2.7.3 Globus Medical Spinal Devices and Biologics Product and Services
2.7.4 Globus Medical Spinal Devices and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Globus Medical Recent Developments/Updates
2.8 K2M
2.8.1 K2M Details
2.8.2 K2M Major Business
2.8.3 K2M Spinal Devices and Biologics Product and Services
2.8.4 K2M Spinal Devices and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 K2M Recent Developments/Updates
2.9 Medtronic
2.9.1 Medtronic Details
2.9.2 Medtronic Major Business
2.9.3 Medtronic Spinal Devices and Biologics Product and Services
2.9.4 Medtronic Spinal Devices and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Medtronic Recent Developments/Updates
2.10 Alphatec Holdings
2.10.1 Alphatec Holdings Details
2.10.2 Alphatec Holdings Major Business
2.10.3 Alphatec Holdings Spinal Devices and Biologics Product and Services
2.10.4 Alphatec Holdings Spinal Devices and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Alphatec Holdings Recent Developments/Updates
2.11 RTI Surgical
2.11.1 RTI Surgical Details
2.11.2 RTI Surgical Major Business
2.11.3 RTI Surgical Spinal Devices and Biologics Product and Services
2.11.4 RTI Surgical Spinal Devices and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 RTI Surgical Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: SPINAL DEVICES AND BIOLOGICS BY MANUFACTURER
3.1 Global Spinal Devices and Biologics Sales Quantity by Manufacturer (2018-2023)
3.2 Global Spinal Devices and Biologics Revenue by Manufacturer (2018-2023)
3.3 Global Spinal Devices and Biologics Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Spinal Devices and Biologics by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Spinal Devices and Biologics Manufacturer Market Share in 2022
3.4.2 Top 6 Spinal Devices and Biologics Manufacturer Market Share in 2022
3.5 Spinal Devices and Biologics Market: Overall Company Footprint Analysis
3.5.1 Spinal Devices and Biologics Market: Region Footprint
3.5.2 Spinal Devices and Biologics Market: Company Product Type Footprint
3.5.3 Spinal Devices and Biologics Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Spinal Devices and Biologics Market Size by Region
4.1.1 Global Spinal Devices and Biologics Sales Quantity by Region (2018-2029)
4.1.2 Global Spinal Devices and Biologics Consumption Value by Region (2018-2029)
4.1.3 Global Spinal Devices and Biologics Average Price by Region (2018-2029)
4.2 North America Spinal Devices and Biologics Consumption Value (2018-2029)
4.3 Europe Spinal Devices and Biologics Consumption Value (2018-2029)
4.4 Asia-Pacific Spinal Devices and Biologics Consumption Value (2018-2029)
4.5 South America Spinal Devices and Biologics Consumption Value (2018-2029)
4.6 Middle East and Africa Spinal Devices and Biologics Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Spinal Devices and Biologics Sales Quantity by Type (2018-2029)
5.2 Global Spinal Devices and Biologics Consumption Value by Type (2018-2029)
5.3 Global Spinal Devices and Biologics Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Spinal Devices and Biologics Sales Quantity by Application (2018-2029)
6.2 Global Spinal Devices and Biologics Consumption Value by Application (2018-2029)
6.3 Global Spinal Devices and Biologics Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Spinal Devices and Biologics Sales Quantity by Type (2018-2029)
7.2 North America Spinal Devices and Biologics Sales Quantity by Application (2018-2029)
7.3 North America Spinal Devices and Biologics Market Size by Country
7.3.1 North America Spinal Devices and Biologics Sales Quantity by Country (2018-2029)
7.3.2 North America Spinal Devices and Biologics Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Spinal Devices and Biologics Sales Quantity by Type (2018-2029)
8.2 Europe Spinal Devices and Biologics Sales Quantity by Application (2018-2029)
8.3 Europe Spinal Devices and Biologics Market Size by Country
8.3.1 Europe Spinal Devices and Biologics Sales Quantity by Country (2018-2029)
8.3.2 Europe Spinal Devices and Biologics Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Spinal Devices and Biologics Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Spinal Devices and Biologics Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Spinal Devices and Biologics Market Size by Region
9.3.1 Asia-Pacific Spinal Devices and Biologics Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Spinal Devices and Biologics Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Spinal Devices and Biologics Sales Quantity by Type (2018-2029)
10.2 South America Spinal Devices and Biologics Sales Quantity by Application (2018-2029)
10.3 South America Spinal Devices and Biologics Market Size by Country
10.3.1 South America Spinal Devices and Biologics Sales Quantity by Country (2018-2029)
10.3.2 South America Spinal Devices and Biologics Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Spinal Devices and Biologics Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Spinal Devices and Biologics Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Spinal Devices and Biologics Market Size by Country
11.3.1 Middle East & Africa Spinal Devices and Biologics Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Spinal Devices and Biologics Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Spinal Devices and Biologics Market Drivers
12.2 Spinal Devices and Biologics Market Restraints
12.3 Spinal Devices and Biologics Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Spinal Devices and Biologics and Key Manufacturers
13.2 Manufacturing Costs Percentage of Spinal Devices and Biologics
13.3 Spinal Devices and Biologics Production Process
13.4 Spinal Devices and Biologics Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Spinal Devices and Biologics Typical Distributors
14.3 Spinal Devices and Biologics Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Spinal Devices and Biologics
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Spinal Devices and Biologics Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Spinal Fusion & Fixation
1.3.3 Motion Preservation
1.3.4 Non-Fusion Technologies
1.3.5 Fracture Treatment
1.3.6 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Spinal Devices and Biologics Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospitals
1.4.3 Ambulatory Surgical Centers
1.4.4 Clinics
1.4.5 Others
1.5 Global Spinal Devices and Biologics Market Size & Forecast
1.5.1 Global Spinal Devices and Biologics Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Spinal Devices and Biologics Sales Quantity (2018-2029)
1.5.3 Global Spinal Devices and Biologics Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Nuvasive
2.1.1 Nuvasive Details
2.1.2 Nuvasive Major Business
2.1.3 Nuvasive Spinal Devices and Biologics Product and Services
2.1.4 Nuvasive Spinal Devices and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Nuvasive Recent Developments/Updates
2.2 Orthofix International
2.2.1 Orthofix International Details
2.2.2 Orthofix International Major Business
2.2.3 Orthofix International Spinal Devices and Biologics Product and Services
2.2.4 Orthofix International Spinal Devices and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Orthofix International Recent Developments/Updates
2.3 Exactech
2.3.1 Exactech Details
2.3.2 Exactech Major Business
2.3.3 Exactech Spinal Devices and Biologics Product and Services
2.3.4 Exactech Spinal Devices and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Exactech Recent Developments/Updates
2.4 Wright Medical Group
2.4.1 Wright Medical Group Details
2.4.2 Wright Medical Group Major Business
2.4.3 Wright Medical Group Spinal Devices and Biologics Product and Services
2.4.4 Wright Medical Group Spinal Devices and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Wright Medical Group Recent Developments/Updates
2.5 Johnson & Johnson
2.5.1 Johnson & Johnson Details
2.5.2 Johnson & Johnson Major Business
2.5.3 Johnson & Johnson Spinal Devices and Biologics Product and Services
2.5.4 Johnson & Johnson Spinal Devices and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Johnson & Johnson Recent Developments/Updates
2.6 Zimmer Biomet
2.6.1 Zimmer Biomet Details
2.6.2 Zimmer Biomet Major Business
2.6.3 Zimmer Biomet Spinal Devices and Biologics Product and Services
2.6.4 Zimmer Biomet Spinal Devices and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Zimmer Biomet Recent Developments/Updates
2.7 Globus Medical
2.7.1 Globus Medical Details
2.7.2 Globus Medical Major Business
2.7.3 Globus Medical Spinal Devices and Biologics Product and Services
2.7.4 Globus Medical Spinal Devices and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Globus Medical Recent Developments/Updates
2.8 K2M
2.8.1 K2M Details
2.8.2 K2M Major Business
2.8.3 K2M Spinal Devices and Biologics Product and Services
2.8.4 K2M Spinal Devices and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 K2M Recent Developments/Updates
2.9 Medtronic
2.9.1 Medtronic Details
2.9.2 Medtronic Major Business
2.9.3 Medtronic Spinal Devices and Biologics Product and Services
2.9.4 Medtronic Spinal Devices and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Medtronic Recent Developments/Updates
2.10 Alphatec Holdings
2.10.1 Alphatec Holdings Details
2.10.2 Alphatec Holdings Major Business
2.10.3 Alphatec Holdings Spinal Devices and Biologics Product and Services
2.10.4 Alphatec Holdings Spinal Devices and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Alphatec Holdings Recent Developments/Updates
2.11 RTI Surgical
2.11.1 RTI Surgical Details
2.11.2 RTI Surgical Major Business
2.11.3 RTI Surgical Spinal Devices and Biologics Product and Services
2.11.4 RTI Surgical Spinal Devices and Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 RTI Surgical Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: SPINAL DEVICES AND BIOLOGICS BY MANUFACTURER
3.1 Global Spinal Devices and Biologics Sales Quantity by Manufacturer (2018-2023)
3.2 Global Spinal Devices and Biologics Revenue by Manufacturer (2018-2023)
3.3 Global Spinal Devices and Biologics Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Spinal Devices and Biologics by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Spinal Devices and Biologics Manufacturer Market Share in 2022
3.4.2 Top 6 Spinal Devices and Biologics Manufacturer Market Share in 2022
3.5 Spinal Devices and Biologics Market: Overall Company Footprint Analysis
3.5.1 Spinal Devices and Biologics Market: Region Footprint
3.5.2 Spinal Devices and Biologics Market: Company Product Type Footprint
3.5.3 Spinal Devices and Biologics Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Spinal Devices and Biologics Market Size by Region
4.1.1 Global Spinal Devices and Biologics Sales Quantity by Region (2018-2029)
4.1.2 Global Spinal Devices and Biologics Consumption Value by Region (2018-2029)
4.1.3 Global Spinal Devices and Biologics Average Price by Region (2018-2029)
4.2 North America Spinal Devices and Biologics Consumption Value (2018-2029)
4.3 Europe Spinal Devices and Biologics Consumption Value (2018-2029)
4.4 Asia-Pacific Spinal Devices and Biologics Consumption Value (2018-2029)
4.5 South America Spinal Devices and Biologics Consumption Value (2018-2029)
4.6 Middle East and Africa Spinal Devices and Biologics Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Spinal Devices and Biologics Sales Quantity by Type (2018-2029)
5.2 Global Spinal Devices and Biologics Consumption Value by Type (2018-2029)
5.3 Global Spinal Devices and Biologics Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Spinal Devices and Biologics Sales Quantity by Application (2018-2029)
6.2 Global Spinal Devices and Biologics Consumption Value by Application (2018-2029)
6.3 Global Spinal Devices and Biologics Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Spinal Devices and Biologics Sales Quantity by Type (2018-2029)
7.2 North America Spinal Devices and Biologics Sales Quantity by Application (2018-2029)
7.3 North America Spinal Devices and Biologics Market Size by Country
7.3.1 North America Spinal Devices and Biologics Sales Quantity by Country (2018-2029)
7.3.2 North America Spinal Devices and Biologics Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Spinal Devices and Biologics Sales Quantity by Type (2018-2029)
8.2 Europe Spinal Devices and Biologics Sales Quantity by Application (2018-2029)
8.3 Europe Spinal Devices and Biologics Market Size by Country
8.3.1 Europe Spinal Devices and Biologics Sales Quantity by Country (2018-2029)
8.3.2 Europe Spinal Devices and Biologics Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Spinal Devices and Biologics Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Spinal Devices and Biologics Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Spinal Devices and Biologics Market Size by Region
9.3.1 Asia-Pacific Spinal Devices and Biologics Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Spinal Devices and Biologics Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Spinal Devices and Biologics Sales Quantity by Type (2018-2029)
10.2 South America Spinal Devices and Biologics Sales Quantity by Application (2018-2029)
10.3 South America Spinal Devices and Biologics Market Size by Country
10.3.1 South America Spinal Devices and Biologics Sales Quantity by Country (2018-2029)
10.3.2 South America Spinal Devices and Biologics Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Spinal Devices and Biologics Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Spinal Devices and Biologics Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Spinal Devices and Biologics Market Size by Country
11.3.1 Middle East & Africa Spinal Devices and Biologics Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Spinal Devices and Biologics Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Spinal Devices and Biologics Market Drivers
12.2 Spinal Devices and Biologics Market Restraints
12.3 Spinal Devices and Biologics Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Spinal Devices and Biologics and Key Manufacturers
13.2 Manufacturing Costs Percentage of Spinal Devices and Biologics
13.3 Spinal Devices and Biologics Production Process
13.4 Spinal Devices and Biologics Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Spinal Devices and Biologics Typical Distributors
14.3 Spinal Devices and Biologics Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Spinal Devices and Biologics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Spinal Devices and Biologics Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Nuvasive Basic Information, Manufacturing Base and Competitors
Table 4. Nuvasive Major Business
Table 5. Nuvasive Spinal Devices and Biologics Product and Services
Table 6. Nuvasive Spinal Devices and Biologics Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Nuvasive Recent Developments/Updates
Table 8. Orthofix International Basic Information, Manufacturing Base and Competitors
Table 9. Orthofix International Major Business
Table 10. Orthofix International Spinal Devices and Biologics Product and Services
Table 11. Orthofix International Spinal Devices and Biologics Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Orthofix International Recent Developments/Updates
Table 13. Exactech Basic Information, Manufacturing Base and Competitors
Table 14. Exactech Major Business
Table 15. Exactech Spinal Devices and Biologics Product and Services
Table 16. Exactech Spinal Devices and Biologics Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Exactech Recent Developments/Updates
Table 18. Wright Medical Group Basic Information, Manufacturing Base and Competitors
Table 19. Wright Medical Group Major Business
Table 20. Wright Medical Group Spinal Devices and Biologics Product and Services
Table 21. Wright Medical Group Spinal Devices and Biologics Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Wright Medical Group Recent Developments/Updates
Table 23. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 24. Johnson & Johnson Major Business
Table 25. Johnson & Johnson Spinal Devices and Biologics Product and Services
Table 26. Johnson & Johnson Spinal Devices and Biologics Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Johnson & Johnson Recent Developments/Updates
Table 28. Zimmer Biomet Basic Information, Manufacturing Base and Competitors
Table 29. Zimmer Biomet Major Business
Table 30. Zimmer Biomet Spinal Devices and Biologics Product and Services
Table 31. Zimmer Biomet Spinal Devices and Biologics Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Zimmer Biomet Recent Developments/Updates
Table 33. Globus Medical Basic Information, Manufacturing Base and Competitors
Table 34. Globus Medical Major Business
Table 35. Globus Medical Spinal Devices and Biologics Product and Services
Table 36. Globus Medical Spinal Devices and Biologics Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Globus Medical Recent Developments/Updates
Table 38. K2M Basic Information, Manufacturing Base and Competitors
Table 39. K2M Major Business
Table 40. K2M Spinal Devices and Biologics Product and Services
Table 41. K2M Spinal Devices and Biologics Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. K2M Recent Developments/Updates
Table 43. Medtronic Basic Information, Manufacturing Base and Competitors
Table 44. Medtronic Major Business
Table 45. Medtronic Spinal Devices and Biologics Product and Services
Table 46. Medtronic Spinal Devices and Biologics Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Medtronic Recent Developments/Updates
Table 48. Alphatec Holdings Basic Information, Manufacturing Base and Competitors
Table 49. Alphatec Holdings Major Business
Table 50. Alphatec Holdings Spinal Devices and Biologics Product and Services
Table 51. Alphatec Holdings Spinal Devices and Biologics Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Alphatec Holdings Recent Developments/Updates
Table 53. RTI Surgical Basic Information, Manufacturing Base and Competitors
Table 54. RTI Surgical Major Business
Table 55. RTI Surgical Spinal Devices and Biologics Product and Services
Table 56. RTI Surgical Spinal Devices and Biologics Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. RTI Surgical Recent Developments/Updates
Table 58. Global Spinal Devices and Biologics Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 59. Global Spinal Devices and Biologics Revenue by Manufacturer (2018-2023) & (USD Million)
Table 60. Global Spinal Devices and Biologics Average Price by Manufacturer (2018-2023) & (USD/Unit)
Table 61. Market Position of Manufacturers in Spinal Devices and Biologics, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 62. Head Office and Spinal Devices and Biologics Production Site of Key Manufacturer
Table 63. Spinal Devices and Biologics Market: Company Product Type Footprint
Table 64. Spinal Devices and Biologics Market: Company Product Application Footprint
Table 65. Spinal Devices and Biologics New Market Entrants and Barriers to Market Entry
Table 66. Spinal Devices and Biologics Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global Spinal Devices and Biologics Sales Quantity by Region (2018-2023) & (K Units)
Table 68. Global Spinal Devices and Biologics Sales Quantity by Region (2024-2029) & (K Units)
Table 69. Global Spinal Devices and Biologics Consumption Value by Region (2018-2023) & (USD Million)
Table 70. Global Spinal Devices and Biologics Consumption Value by Region (2024-2029) & (USD Million)
Table 71. Global Spinal Devices and Biologics Average Price by Region (2018-2023) & (USD/Unit)
Table 72. Global Spinal Devices and Biologics Average Price by Region (2024-2029) & (USD/Unit)
Table 73. Global Spinal Devices and Biologics Sales Quantity by Type (2018-2023) & (K Units)
Table 74. Global Spinal Devices and Biologics Sales Quantity by Type (2024-2029) & (K Units)
Table 75. Global Spinal Devices and Biologics Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Global Spinal Devices and Biologics Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Global Spinal Devices and Biologics Average Price by Type (2018-2023) & (USD/Unit)
Table 78. Global Spinal Devices and Biologics Average Price by Type (2024-2029) & (USD/Unit)
Table 79. Global Spinal Devices and Biologics Sales Quantity by Application (2018-2023) & (K Units)
Table 80. Global Spinal Devices and Biologics Sales Quantity by Application (2024-2029) & (K Units)
Table 81. Global Spinal Devices and Biologics Consumption Value by Application (2018-2023) & (USD Million)
Table 82. Global Spinal Devices and Biologics Consumption Value by Application (2024-2029) & (USD Million)
Table 83. Global Spinal Devices and Biologics Average Price by Application (2018-2023) & (USD/Unit)
Table 84. Global Spinal Devices and Biologics Average Price by Application (2024-2029) & (USD/Unit)
Table 85. North America Spinal Devices and Biologics Sales Quantity by Type (2018-2023) & (K Units)
Table 86. North America Spinal Devices and Biologics Sales Quantity by Type (2024-2029) & (K Units)
Table 87. North America Spinal Devices and Biologics Sales Quantity by Application (2018-2023) & (K Units)
Table 88. North America Spinal Devices and Biologics Sales Quantity by Application (2024-2029) & (K Units)
Table 89. North America Spinal Devices and Biologics Sales Quantity by Country (2018-2023) & (K Units)
Table 90. North America Spinal Devices and Biologics Sales Quantity by Country (2024-2029) & (K Units)
Table 91. North America Spinal Devices and Biologics Consumption Value by Country (2018-2023) & (USD Million)
Table 92. North America Spinal Devices and Biologics Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Europe Spinal Devices and Biologics Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Europe Spinal Devices and Biologics Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Europe Spinal Devices and Biologics Sales Quantity by Application (2018-2023) & (K Units)
Table 96. Europe Spinal Devices and Biologics Sales Quantity by Application (2024-2029) & (K Units)
Table 97. Europe Spinal Devices and Biologics Sales Quantity by Country (2018-2023) & (K Units)
Table 98. Europe Spinal Devices and Biologics Sales Quantity by Country (2024-2029) & (K Units)
Table 99. Europe Spinal Devices and Biologics Consumption Value by Country (2018-2023) & (USD Million)
Table 100. Europe Spinal Devices and Biologics Consumption Value by Country (2024-2029) & (USD Million)
Table 101. Asia-Pacific Spinal Devices and Biologics Sales Quantity by Type (2018-2023) & (K Units)
Table 102. Asia-Pacific Spinal Devices and Biologics Sales Quantity by Type (2024-2029) & (K Units)
Table 103. Asia-Pacific Spinal Devices and Biologics Sales Quantity by Application (2018-2023) & (K Units)
Table 104. Asia-Pacific Spinal Devices and Biologics Sales Quantity by Application (2024-2029) & (K Units)
Table 105. Asia-Pacific Spinal Devices and Biologics Sales Quantity by Region (2018-2023) & (K Units)
Table 106. Asia-Pacific Spinal Devices and Biologics Sales Quantity by Region (2024-2029) & (K Units)
Table 107. Asia-Pacific Spinal Devices and Biologics Consumption Value by Region (2018-2023) & (USD Million)
Table 108. Asia-Pacific Spinal Devices and Biologics Consumption Value by Region (2024-2029) & (USD Million)
Table 109. South America Spinal Devices and Biologics Sales Quantity by Type (2018-2023) & (K Units)
Table 110. South America Spinal Devices and Biologics Sales Quantity by Type (2024-2029) & (K Units)
Table 111. South America Spinal Devices and Biologics Sales Quantity by Application (2018-2023) & (K Units)
Table 112. South America Spinal Devices and Biologics Sales Quantity by Application (2024-2029) & (K Units)
Table 113. South America Spinal Devices and Biologics Sales Quantity by Country (2018-2023) & (K Units)
Table 114. South America Spinal Devices and Biologics Sales Quantity by Country (2024-2029) & (K Units)
Table 115. South America Spinal Devices and Biologics Consumption Value by Country (2018-2023) & (USD Million)
Table 116. South America Spinal Devices and Biologics Consumption Value by Country (2024-2029) & (USD Million)
Table 117. Middle East & Africa Spinal Devices and Biologics Sales Quantity by Type (2018-2023) & (K Units)
Table 118. Middle East & Africa Spinal Devices and Biologics Sales Quantity by Type (2024-2029) & (K Units)
Table 119. Middle East & Africa Spinal Devices and Biologics Sales Quantity by Application (2018-2023) & (K Units)
Table 120. Middle East & Africa Spinal Devices and Biologics Sales Quantity by Application (2024-2029) & (K Units)
Table 121. Middle East & Africa Spinal Devices and Biologics Sales Quantity by Region (2018-2023) & (K Units)
Table 122. Middle East & Africa Spinal Devices and Biologics Sales Quantity by Region (2024-2029) & (K Units)
Table 123. Middle East & Africa Spinal Devices and Biologics Consumption Value by Region (2018-2023) & (USD Million)
Table 124. Middle East & Africa Spinal Devices and Biologics Consumption Value by Region (2024-2029) & (USD Million)
Table 125. Spinal Devices and Biologics Raw Material
Table 126. Key Manufacturers of Spinal Devices and Biologics Raw Materials
Table 127. Spinal Devices and Biologics Typical Distributors
Table 128. Spinal Devices and Biologics Typical Customers
Table 1. Global Spinal Devices and Biologics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Spinal Devices and Biologics Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Nuvasive Basic Information, Manufacturing Base and Competitors
Table 4. Nuvasive Major Business
Table 5. Nuvasive Spinal Devices and Biologics Product and Services
Table 6. Nuvasive Spinal Devices and Biologics Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Nuvasive Recent Developments/Updates
Table 8. Orthofix International Basic Information, Manufacturing Base and Competitors
Table 9. Orthofix International Major Business
Table 10. Orthofix International Spinal Devices and Biologics Product and Services
Table 11. Orthofix International Spinal Devices and Biologics Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Orthofix International Recent Developments/Updates
Table 13. Exactech Basic Information, Manufacturing Base and Competitors
Table 14. Exactech Major Business
Table 15. Exactech Spinal Devices and Biologics Product and Services
Table 16. Exactech Spinal Devices and Biologics Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Exactech Recent Developments/Updates
Table 18. Wright Medical Group Basic Information, Manufacturing Base and Competitors
Table 19. Wright Medical Group Major Business
Table 20. Wright Medical Group Spinal Devices and Biologics Product and Services
Table 21. Wright Medical Group Spinal Devices and Biologics Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Wright Medical Group Recent Developments/Updates
Table 23. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 24. Johnson & Johnson Major Business
Table 25. Johnson & Johnson Spinal Devices and Biologics Product and Services
Table 26. Johnson & Johnson Spinal Devices and Biologics Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Johnson & Johnson Recent Developments/Updates
Table 28. Zimmer Biomet Basic Information, Manufacturing Base and Competitors
Table 29. Zimmer Biomet Major Business
Table 30. Zimmer Biomet Spinal Devices and Biologics Product and Services
Table 31. Zimmer Biomet Spinal Devices and Biologics Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Zimmer Biomet Recent Developments/Updates
Table 33. Globus Medical Basic Information, Manufacturing Base and Competitors
Table 34. Globus Medical Major Business
Table 35. Globus Medical Spinal Devices and Biologics Product and Services
Table 36. Globus Medical Spinal Devices and Biologics Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Globus Medical Recent Developments/Updates
Table 38. K2M Basic Information, Manufacturing Base and Competitors
Table 39. K2M Major Business
Table 40. K2M Spinal Devices and Biologics Product and Services
Table 41. K2M Spinal Devices and Biologics Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. K2M Recent Developments/Updates
Table 43. Medtronic Basic Information, Manufacturing Base and Competitors
Table 44. Medtronic Major Business
Table 45. Medtronic Spinal Devices and Biologics Product and Services
Table 46. Medtronic Spinal Devices and Biologics Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Medtronic Recent Developments/Updates
Table 48. Alphatec Holdings Basic Information, Manufacturing Base and Competitors
Table 49. Alphatec Holdings Major Business
Table 50. Alphatec Holdings Spinal Devices and Biologics Product and Services
Table 51. Alphatec Holdings Spinal Devices and Biologics Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Alphatec Holdings Recent Developments/Updates
Table 53. RTI Surgical Basic Information, Manufacturing Base and Competitors
Table 54. RTI Surgical Major Business
Table 55. RTI Surgical Spinal Devices and Biologics Product and Services
Table 56. RTI Surgical Spinal Devices and Biologics Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. RTI Surgical Recent Developments/Updates
Table 58. Global Spinal Devices and Biologics Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 59. Global Spinal Devices and Biologics Revenue by Manufacturer (2018-2023) & (USD Million)
Table 60. Global Spinal Devices and Biologics Average Price by Manufacturer (2018-2023) & (USD/Unit)
Table 61. Market Position of Manufacturers in Spinal Devices and Biologics, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 62. Head Office and Spinal Devices and Biologics Production Site of Key Manufacturer
Table 63. Spinal Devices and Biologics Market: Company Product Type Footprint
Table 64. Spinal Devices and Biologics Market: Company Product Application Footprint
Table 65. Spinal Devices and Biologics New Market Entrants and Barriers to Market Entry
Table 66. Spinal Devices and Biologics Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global Spinal Devices and Biologics Sales Quantity by Region (2018-2023) & (K Units)
Table 68. Global Spinal Devices and Biologics Sales Quantity by Region (2024-2029) & (K Units)
Table 69. Global Spinal Devices and Biologics Consumption Value by Region (2018-2023) & (USD Million)
Table 70. Global Spinal Devices and Biologics Consumption Value by Region (2024-2029) & (USD Million)
Table 71. Global Spinal Devices and Biologics Average Price by Region (2018-2023) & (USD/Unit)
Table 72. Global Spinal Devices and Biologics Average Price by Region (2024-2029) & (USD/Unit)
Table 73. Global Spinal Devices and Biologics Sales Quantity by Type (2018-2023) & (K Units)
Table 74. Global Spinal Devices and Biologics Sales Quantity by Type (2024-2029) & (K Units)
Table 75. Global Spinal Devices and Biologics Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Global Spinal Devices and Biologics Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Global Spinal Devices and Biologics Average Price by Type (2018-2023) & (USD/Unit)
Table 78. Global Spinal Devices and Biologics Average Price by Type (2024-2029) & (USD/Unit)
Table 79. Global Spinal Devices and Biologics Sales Quantity by Application (2018-2023) & (K Units)
Table 80. Global Spinal Devices and Biologics Sales Quantity by Application (2024-2029) & (K Units)
Table 81. Global Spinal Devices and Biologics Consumption Value by Application (2018-2023) & (USD Million)
Table 82. Global Spinal Devices and Biologics Consumption Value by Application (2024-2029) & (USD Million)
Table 83. Global Spinal Devices and Biologics Average Price by Application (2018-2023) & (USD/Unit)
Table 84. Global Spinal Devices and Biologics Average Price by Application (2024-2029) & (USD/Unit)
Table 85. North America Spinal Devices and Biologics Sales Quantity by Type (2018-2023) & (K Units)
Table 86. North America Spinal Devices and Biologics Sales Quantity by Type (2024-2029) & (K Units)
Table 87. North America Spinal Devices and Biologics Sales Quantity by Application (2018-2023) & (K Units)
Table 88. North America Spinal Devices and Biologics Sales Quantity by Application (2024-2029) & (K Units)
Table 89. North America Spinal Devices and Biologics Sales Quantity by Country (2018-2023) & (K Units)
Table 90. North America Spinal Devices and Biologics Sales Quantity by Country (2024-2029) & (K Units)
Table 91. North America Spinal Devices and Biologics Consumption Value by Country (2018-2023) & (USD Million)
Table 92. North America Spinal Devices and Biologics Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Europe Spinal Devices and Biologics Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Europe Spinal Devices and Biologics Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Europe Spinal Devices and Biologics Sales Quantity by Application (2018-2023) & (K Units)
Table 96. Europe Spinal Devices and Biologics Sales Quantity by Application (2024-2029) & (K Units)
Table 97. Europe Spinal Devices and Biologics Sales Quantity by Country (2018-2023) & (K Units)
Table 98. Europe Spinal Devices and Biologics Sales Quantity by Country (2024-2029) & (K Units)
Table 99. Europe Spinal Devices and Biologics Consumption Value by Country (2018-2023) & (USD Million)
Table 100. Europe Spinal Devices and Biologics Consumption Value by Country (2024-2029) & (USD Million)
Table 101. Asia-Pacific Spinal Devices and Biologics Sales Quantity by Type (2018-2023) & (K Units)
Table 102. Asia-Pacific Spinal Devices and Biologics Sales Quantity by Type (2024-2029) & (K Units)
Table 103. Asia-Pacific Spinal Devices and Biologics Sales Quantity by Application (2018-2023) & (K Units)
Table 104. Asia-Pacific Spinal Devices and Biologics Sales Quantity by Application (2024-2029) & (K Units)
Table 105. Asia-Pacific Spinal Devices and Biologics Sales Quantity by Region (2018-2023) & (K Units)
Table 106. Asia-Pacific Spinal Devices and Biologics Sales Quantity by Region (2024-2029) & (K Units)
Table 107. Asia-Pacific Spinal Devices and Biologics Consumption Value by Region (2018-2023) & (USD Million)
Table 108. Asia-Pacific Spinal Devices and Biologics Consumption Value by Region (2024-2029) & (USD Million)
Table 109. South America Spinal Devices and Biologics Sales Quantity by Type (2018-2023) & (K Units)
Table 110. South America Spinal Devices and Biologics Sales Quantity by Type (2024-2029) & (K Units)
Table 111. South America Spinal Devices and Biologics Sales Quantity by Application (2018-2023) & (K Units)
Table 112. South America Spinal Devices and Biologics Sales Quantity by Application (2024-2029) & (K Units)
Table 113. South America Spinal Devices and Biologics Sales Quantity by Country (2018-2023) & (K Units)
Table 114. South America Spinal Devices and Biologics Sales Quantity by Country (2024-2029) & (K Units)
Table 115. South America Spinal Devices and Biologics Consumption Value by Country (2018-2023) & (USD Million)
Table 116. South America Spinal Devices and Biologics Consumption Value by Country (2024-2029) & (USD Million)
Table 117. Middle East & Africa Spinal Devices and Biologics Sales Quantity by Type (2018-2023) & (K Units)
Table 118. Middle East & Africa Spinal Devices and Biologics Sales Quantity by Type (2024-2029) & (K Units)
Table 119. Middle East & Africa Spinal Devices and Biologics Sales Quantity by Application (2018-2023) & (K Units)
Table 120. Middle East & Africa Spinal Devices and Biologics Sales Quantity by Application (2024-2029) & (K Units)
Table 121. Middle East & Africa Spinal Devices and Biologics Sales Quantity by Region (2018-2023) & (K Units)
Table 122. Middle East & Africa Spinal Devices and Biologics Sales Quantity by Region (2024-2029) & (K Units)
Table 123. Middle East & Africa Spinal Devices and Biologics Consumption Value by Region (2018-2023) & (USD Million)
Table 124. Middle East & Africa Spinal Devices and Biologics Consumption Value by Region (2024-2029) & (USD Million)
Table 125. Spinal Devices and Biologics Raw Material
Table 126. Key Manufacturers of Spinal Devices and Biologics Raw Materials
Table 127. Spinal Devices and Biologics Typical Distributors
Table 128. Spinal Devices and Biologics Typical Customers
LIST OF FIGURES
Figure 1. Spinal Devices and Biologics Picture
Figure 2. Global Spinal Devices and Biologics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Spinal Devices and Biologics Consumption Value Market Share by Type in 2022
Figure 4. Spinal Fusion & Fixation Examples
Figure 5. Motion Preservation Examples
Figure 6. Non-Fusion Technologies Examples
Figure 7. Fracture Treatment Examples
Figure 8. Others Examples
Figure 9. Global Spinal Devices and Biologics Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 10. Global Spinal Devices and Biologics Consumption Value Market Share by Application in 2022
Figure 11. Hospitals Examples
Figure 12. Ambulatory Surgical Centers Examples
Figure 13. Clinics Examples
Figure 14. Others Examples
Figure 15. Global Spinal Devices and Biologics Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 16. Global Spinal Devices and Biologics Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 17. Global Spinal Devices and Biologics Sales Quantity (2018-2029) & (K Units)
Figure 18. Global Spinal Devices and Biologics Average Price (2018-2029) & (USD/Unit)
Figure 19. Global Spinal Devices and Biologics Sales Quantity Market Share by Manufacturer in 2022
Figure 20. Global Spinal Devices and Biologics Consumption Value Market Share by Manufacturer in 2022
Figure 21. Producer Shipments of Spinal Devices and Biologics by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 22. Top 3 Spinal Devices and Biologics Manufacturer (Consumption Value) Market Share in 2022
Figure 23. Top 6 Spinal Devices and Biologics Manufacturer (Consumption Value) Market Share in 2022
Figure 24. Global Spinal Devices and Biologics Sales Quantity Market Share by Region (2018-2029)
Figure 25. Global Spinal Devices and Biologics Consumption Value Market Share by Region (2018-2029)
Figure 26. North America Spinal Devices and Biologics Consumption Value (2018-2029) & (USD Million)
Figure 27. Europe Spinal Devices and Biologics Consumption Value (2018-2029) & (USD Million)
Figure 28. Asia-Pacific Spinal Devices and Biologics Consumption Value (2018-2029) & (USD Million)
Figure 29. South America Spinal Devices and Biologics Consumption Value (2018-2029) & (USD Million)
Figure 30. Middle East & Africa Spinal Devices and Biologics Consumption Value (2018-2029) & (USD Million)
Figure 31. Global Spinal Devices and Biologics Sales Quantity Market Share by Type (2018-2029)
Figure 32. Global Spinal Devices and Biologics Consumption Value Market Share by Type (2018-2029)
Figure 33. Global Spinal Devices and Biologics Average Price by Type (2018-2029) & (USD/Unit)
Figure 34. Global Spinal Devices and Biologics Sales Quantity Market Share by Application (2018-2029)
Figure 35. Global Spinal Devices and Biologics Consumption Value Market Share by Application (2018-2029)
Figure 36. Global Spinal Devices and Biologics Average Price by Application (2018-2029) & (USD/Unit)
Figure 37. North America Spinal Devices and Biologics Sales Quantity Market Share by Type (2018-2029)
Figure 38. North America Spinal Devices and Biologics Sales Quantity Market Share by Application (2018-2029)
Figure 39. North America Spinal Devices and Biologics Sales Quantity Market Share by Country (2018-2029)
Figure 40. North America Spinal Devices and Biologics Consumption Value Market Share by Country (2018-2029)
Figure 41. United States Spinal Devices and Biologics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Canada Spinal Devices and Biologics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Mexico Spinal Devices and Biologics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. Europe Spinal Devices and Biologics Sales Quantity Market Share by Type (2018-2029)
Figure 45. Europe Spinal Devices and Biologics Sales Quantity Market Share by Application (2018-2029)
Figure 46. Europe Spinal Devices and Biologics Sales Quantity Market Share by Country (2018-2029)
Figure 47. Europe Spinal Devices and Biologics Consumption Value Market Share by Country (2018-2029)
Figure 48. Germany Spinal Devices and Biologics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. France Spinal Devices and Biologics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. United Kingdom Spinal Devices and Biologics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Russia Spinal Devices and Biologics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Italy Spinal Devices and Biologics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Asia-Pacific Spinal Devices and Biologics Sales Quantity Market Share by Type (2018-2029)
Figure 54. Asia-Pacific Spinal Devices and Biologics Sales Quantity Market Share by Application (2018-2029)
Figure 55. Asia-Pacific Spinal Devices and Biologics Sales Quantity Market Share by Region (2018-2029)
Figure 56. Asia-Pacific Spinal Devices and Biologics Consumption Value Market Share by Region (2018-2029)
Figure 57. China Spinal Devices and Biologics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Japan Spinal Devices and Biologics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Korea Spinal Devices and Biologics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. India Spinal Devices and Biologics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Southeast Asia Spinal Devices and Biologics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. Australia Spinal Devices and Biologics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. South America Spinal Devices and Biologics Sales Quantity Market Share by Type (2018-2029)
Figure 64. South America Spinal Devices and Biologics Sales Quantity Market Share by Application (2018-2029)
Figure 65. South America Spinal Devices and Biologics Sales Quantity Market Share by Country (2018-2029)
Figure 66. South America Spinal Devices and Biologics Consumption Value Market Share by Country (2018-2029)
Figure 67. Brazil Spinal Devices and Biologics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 68. Argentina Spinal Devices and Biologics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Middle East & Africa Spinal Devices and Biologics Sales Quantity Market Share by Type (2018-2029)
Figure 70. Middle East & Africa Spinal Devices and Biologics Sales Quantity Market Share by Application (2018-2029)
Figure 71. Middle East & Africa Spinal Devices and Biologics Sales Quantity Market Share by Region (2018-2029)
Figure 72. Middle East & Africa Spinal Devices and Biologics Consumption Value Market Share by Region (2018-2029)
Figure 73. Turkey Spinal Devices and Biologics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Egypt Spinal Devices and Biologics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Saudi Arabia Spinal Devices and Biologics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. South Africa Spinal Devices and Biologics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 77. Spinal Devices and Biologics Market Drivers
Figure 78. Spinal Devices and Biologics Market Restraints
Figure 79. Spinal Devices and Biologics Market Trends
Figure 80. Porters Five Forces Analysis
Figure 81. Manufacturing Cost Structure Analysis of Spinal Devices and Biologics in 2022
Figure 82. Manufacturing Process Analysis of Spinal Devices and Biologics
Figure 83. Spinal Devices and Biologics Industrial Chain
Figure 84. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 85. Direct Channel Pros & Cons
Figure 86. Indirect Channel Pros & Cons
Figure 87. Methodology
Figure 88. Research Process and Data Source
Figure 1. Spinal Devices and Biologics Picture
Figure 2. Global Spinal Devices and Biologics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Spinal Devices and Biologics Consumption Value Market Share by Type in 2022
Figure 4. Spinal Fusion & Fixation Examples
Figure 5. Motion Preservation Examples
Figure 6. Non-Fusion Technologies Examples
Figure 7. Fracture Treatment Examples
Figure 8. Others Examples
Figure 9. Global Spinal Devices and Biologics Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 10. Global Spinal Devices and Biologics Consumption Value Market Share by Application in 2022
Figure 11. Hospitals Examples
Figure 12. Ambulatory Surgical Centers Examples
Figure 13. Clinics Examples
Figure 14. Others Examples
Figure 15. Global Spinal Devices and Biologics Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 16. Global Spinal Devices and Biologics Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 17. Global Spinal Devices and Biologics Sales Quantity (2018-2029) & (K Units)
Figure 18. Global Spinal Devices and Biologics Average Price (2018-2029) & (USD/Unit)
Figure 19. Global Spinal Devices and Biologics Sales Quantity Market Share by Manufacturer in 2022
Figure 20. Global Spinal Devices and Biologics Consumption Value Market Share by Manufacturer in 2022
Figure 21. Producer Shipments of Spinal Devices and Biologics by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 22. Top 3 Spinal Devices and Biologics Manufacturer (Consumption Value) Market Share in 2022
Figure 23. Top 6 Spinal Devices and Biologics Manufacturer (Consumption Value) Market Share in 2022
Figure 24. Global Spinal Devices and Biologics Sales Quantity Market Share by Region (2018-2029)
Figure 25. Global Spinal Devices and Biologics Consumption Value Market Share by Region (2018-2029)
Figure 26. North America Spinal Devices and Biologics Consumption Value (2018-2029) & (USD Million)
Figure 27. Europe Spinal Devices and Biologics Consumption Value (2018-2029) & (USD Million)
Figure 28. Asia-Pacific Spinal Devices and Biologics Consumption Value (2018-2029) & (USD Million)
Figure 29. South America Spinal Devices and Biologics Consumption Value (2018-2029) & (USD Million)
Figure 30. Middle East & Africa Spinal Devices and Biologics Consumption Value (2018-2029) & (USD Million)
Figure 31. Global Spinal Devices and Biologics Sales Quantity Market Share by Type (2018-2029)
Figure 32. Global Spinal Devices and Biologics Consumption Value Market Share by Type (2018-2029)
Figure 33. Global Spinal Devices and Biologics Average Price by Type (2018-2029) & (USD/Unit)
Figure 34. Global Spinal Devices and Biologics Sales Quantity Market Share by Application (2018-2029)
Figure 35. Global Spinal Devices and Biologics Consumption Value Market Share by Application (2018-2029)
Figure 36. Global Spinal Devices and Biologics Average Price by Application (2018-2029) & (USD/Unit)
Figure 37. North America Spinal Devices and Biologics Sales Quantity Market Share by Type (2018-2029)
Figure 38. North America Spinal Devices and Biologics Sales Quantity Market Share by Application (2018-2029)
Figure 39. North America Spinal Devices and Biologics Sales Quantity Market Share by Country (2018-2029)
Figure 40. North America Spinal Devices and Biologics Consumption Value Market Share by Country (2018-2029)
Figure 41. United States Spinal Devices and Biologics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Canada Spinal Devices and Biologics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Mexico Spinal Devices and Biologics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. Europe Spinal Devices and Biologics Sales Quantity Market Share by Type (2018-2029)
Figure 45. Europe Spinal Devices and Biologics Sales Quantity Market Share by Application (2018-2029)
Figure 46. Europe Spinal Devices and Biologics Sales Quantity Market Share by Country (2018-2029)
Figure 47. Europe Spinal Devices and Biologics Consumption Value Market Share by Country (2018-2029)
Figure 48. Germany Spinal Devices and Biologics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. France Spinal Devices and Biologics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. United Kingdom Spinal Devices and Biologics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Russia Spinal Devices and Biologics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Italy Spinal Devices and Biologics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Asia-Pacific Spinal Devices and Biologics Sales Quantity Market Share by Type (2018-2029)
Figure 54. Asia-Pacific Spinal Devices and Biologics Sales Quantity Market Share by Application (2018-2029)
Figure 55. Asia-Pacific Spinal Devices and Biologics Sales Quantity Market Share by Region (2018-2029)
Figure 56. Asia-Pacific Spinal Devices and Biologics Consumption Value Market Share by Region (2018-2029)
Figure 57. China Spinal Devices and Biologics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Japan Spinal Devices and Biologics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Korea Spinal Devices and Biologics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. India Spinal Devices and Biologics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Southeast Asia Spinal Devices and Biologics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. Australia Spinal Devices and Biologics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. South America Spinal Devices and Biologics Sales Quantity Market Share by Type (2018-2029)
Figure 64. South America Spinal Devices and Biologics Sales Quantity Market Share by Application (2018-2029)
Figure 65. South America Spinal Devices and Biologics Sales Quantity Market Share by Country (2018-2029)
Figure 66. South America Spinal Devices and Biologics Consumption Value Market Share by Country (2018-2029)
Figure 67. Brazil Spinal Devices and Biologics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 68. Argentina Spinal Devices and Biologics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Middle East & Africa Spinal Devices and Biologics Sales Quantity Market Share by Type (2018-2029)
Figure 70. Middle East & Africa Spinal Devices and Biologics Sales Quantity Market Share by Application (2018-2029)
Figure 71. Middle East & Africa Spinal Devices and Biologics Sales Quantity Market Share by Region (2018-2029)
Figure 72. Middle East & Africa Spinal Devices and Biologics Consumption Value Market Share by Region (2018-2029)
Figure 73. Turkey Spinal Devices and Biologics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Egypt Spinal Devices and Biologics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Saudi Arabia Spinal Devices and Biologics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. South Africa Spinal Devices and Biologics Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 77. Spinal Devices and Biologics Market Drivers
Figure 78. Spinal Devices and Biologics Market Restraints
Figure 79. Spinal Devices and Biologics Market Trends
Figure 80. Porters Five Forces Analysis
Figure 81. Manufacturing Cost Structure Analysis of Spinal Devices and Biologics in 2022
Figure 82. Manufacturing Process Analysis of Spinal Devices and Biologics
Figure 83. Spinal Devices and Biologics Industrial Chain
Figure 84. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 85. Direct Channel Pros & Cons
Figure 86. Indirect Channel Pros & Cons
Figure 87. Methodology
Figure 88. Research Process and Data Source
